Accuray Incorporated (ARAY): Price and Financial Metrics


Accuray Incorporated (ARAY): $2.17

0.09 (+4.33%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ARAY POWR Grades

  • Value is the dimension where ARAY ranks best; there it ranks ahead of 97.95% of US stocks.
  • The strongest trend for ARAY is in Quality, which has been heading down over the past 177 days.
  • ARAY's current lowest rank is in the Momentum metric (where it is better than 10.82% of US stocks).

ARAY Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ARAY is 8.08 -- better than 95.63% of US stocks.
  • With a price/sales ratio of 0.43, ACCURAY INC has a higher such ratio than only 14.89% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 9.39 for ACCURAY INC; that's greater than it is for 90.19% of US stocks.
  • Stocks that are quantitatively similar to ARAY, based on their financial statements, market capitalization, and price volatility, are THTX, EXTR, AVEO, DZSI, and ALKS.
  • ARAY's SEC filings can be seen here. And to visit ACCURAY INC's official web site, go to www.accuray.com.

ARAY Valuation Summary

  • In comparison to the median Healthcare stock, ARAY's price/sales ratio is 78.95% lower, now standing at 0.4.
  • Over the past 190 months, ARAY's price/sales ratio has gone down 14.1.

Below are key valuation metrics over time for ARAY.

Stock Date P/S P/B P/E EV/EBIT
ARAY 2022-09-23 0.4 3.6 -35.9 -150.3
ARAY 2022-09-22 0.5 3.7 -37.3 -154.1
ARAY 2022-09-21 0.5 3.8 -37.8 -155.5
ARAY 2022-09-20 0.5 3.8 -37.8 -155.5
ARAY 2022-09-19 0.5 3.9 -39.0 -158.7
ARAY 2022-09-16 0.5 3.9 -38.3 -156.9

ARAY Growth Metrics

    The 3 year price growth rate now stands at -36.36%.
  • The 2 year cash and equivalents growth rate now stands at 7.21%.
  • Its 3 year revenue growth rate is now at 3.77%.
Over the past 33 months, ARAY's revenue has gone up $17,376,000.

The table below shows ARAY's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 429.909 -2.4 -5.347
2022-03-31 430.822 8.439 -12.987
2021-12-31 437.215 46.109 -12.331
2021-09-30 418.399 32.782 -7.741
2021-06-30 396.289 38.512 -6.311
2021-03-31 380.33 51.136 4.629

ARAY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ARAY has a Quality Grade of C, ranking ahead of 70.31% of graded US stocks.
  • ARAY's asset turnover comes in at 0.83 -- ranking 35th of 186 Medical Equipment stocks.
  • ATRC, INGN, and GKOS are the stocks whose asset turnover ratios are most correlated with ARAY.

The table below shows ARAY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.830 0.403 -0.014
2021-03-31 0.792 0.409 0.018
2020-12-31 0.785 0.411 0.025
2020-09-30 0.787 0.402 0.042
2020-06-30 0.796 0.391 0.016
2020-03-31 0.866 0.385 0.015

ARAY Price Target

For more insight on analysts targets of ARAY, see our ARAY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $8.20 Average Broker Recommendation 1.3 (Strong Buy)

ARAY Stock Price Chart Interactive Chart >

Price chart for ARAY

ARAY Price/Volume Stats

Current price $2.17 52-week high $5.93
Prev. close $2.08 52-week low $1.70
Day low $2.07 Volume 551,400
Day high $2.20 Avg. volume 856,608
50-day MA $2.33 Dividend yield N/A
200-day MA $2.97 Market Cap 202.90M

Accuray Incorporated (ARAY) Company Bio


Accuray Inc. designs, develops, and sells radio-surgery and radiation therapy systems for the treatment of tumors in the body. It offers the CyberKnife System, a robotic stereotactic radio-surgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The company was founded in 1990 and is based in Sunnyvale, California.


ARAY Latest News Stream


Event/Time News Detail
Loading, please wait...

ARAY Latest Social Stream


Loading social stream, please wait...

View Full ARAY Social Stream

Latest ARAY News From Around the Web

Below are the latest news stories about ACCURAY INC that investors may wish to consider to help them evaluate ARAY as an investment opportunity.

Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region

Accuray Incorporated (NASDAQ: ARAY) announced today that Seth Blacksburg, M.D., MBA has joined the company as vice president, chief medical officer for the Americas (North and South America) region. Dr. Blacksburg will be responsible for bringing the strategic clinical insights, real-world experience and voice of the customer necessary to help drive the continued commercial growth of the region. He will report to Mike Leischer, Accuray president and general manager for the Americas region.

Yahoo | September 14, 2022

Accuray's (ARAY) Latest Collaboration to Improve Patient Care

Accuray (ARAY) partners with Genolier Innovation Hub to unite companies from the MedTech, pharma and biosciences sectors with physicians and scientists for better patient outcomes.

Yahoo | September 8, 2022

Accuray Partners with Swiss-based Genolier Innovation Hub to Bring Medical and Technological Advances to Patients Faster

Accuray Incorporated (NASDAQ: ARAY) announced today the company is joining forces with Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA (SWX: AEVS), in support of a unique new approach to improving patient care. Genolier Innovation Hub will unite companies from the medtech, pharma and biosciences sectors, physicians and scientists, under one roof, with the goal of bringing medical and technological advances to patients faster. The Hub is expected to open in early 2024.

Yahoo | September 7, 2022

Accuray's (NASDAQ:ARAY) Returns On Capital Are Heading Higher

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...

Yahoo | September 5, 2022

Are Options Traders Betting on a Big Move in Accuray (ARAY) Stock?

Investors need to pay close attention to Accuray (ARAY) stock based on the movements in the options market lately.

Yahoo | August 19, 2022

Read More 'ARAY' Stories Here

ARAY Price Returns

1-mo -11.79%
3-mo 13.02%
6-mo -35.80%
1-year -45.34%
3-year -21.66%
5-year -45.75%
YTD -54.51%
2021 14.39%
2020 47.87%
2019 -17.30%
2018 -20.70%
2017 -6.52%

Continue Researching ARAY

Want to see what other sources are saying about Accuray Inc's financials and stock price? Try the links below:

Accuray Inc (ARAY) Stock Price | Nasdaq
Accuray Inc (ARAY) Stock Quote, History and News - Yahoo Finance
Accuray Inc (ARAY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7369 seconds.